CannaRoyalty CorpCSE: CRZ

CannaRoyalty Announces its First Quarter 2018 Financial Results

· Issued by CannaRoyalty Corp via CNW

Key figures

  • Revenues were $643,437 as compared to $301,111 .
  • Gross margin was ($29,630) as compared to $244,473 .
  • Operating expenses were $4.5 million as compared to $3.1 million .
  • Net loss of $4.7 million as compared to $2.1 million .
  • Net loss per share of $0.10 as compared to $0.05 .

On 6ix: 6ix.com/news/cannaroyalty-announces-its-first-quarter-2018-financial-results

OTTAWA, May 29, 2018 /CNW/ - CannaRoyalty Corp. (CSE: CRZ) (OTCQX: CNNRF) ("CannaRoyalty" or the "Company") today announced the Company's financial results for the three-month period ended March 31, 2018. All figures are reported in Canadian dollars ($), unless otherwise indicated. CannaRoyalty's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

"Over the past six months, we have announced the acquisition of substantial revenue generating cannabis operators, including distribution operations that generated US$31.9 million in revenue in 2017, transforming CannaRoyalty into a major cannabis product distributor in California and into what we expect will be one of the largest revenue producers in the Canadian publicly-traded cannabis space," said Marc Lustig, CEO of CannaRoyalty. "Our team has targeted distribution not only for its attractive near-term economic potential but also for its strategic position between California's leading growth brands and most licensed dispensaries in the state. By fostering strategic relationships with both constituencies, we expect to generate significant organic growth, while building an information advantage and poll position to assess and execute on accretive opportunities for the Company. Over the past several months we have also established a beachhead in Canada to eventually bring our leading products home and we expect to continue to make progress on this significant opportunity over the balance of the year and as the Canadian regulations continue to develop."

Q1 Highlights and Recent Developments

For a more comprehensive overview of these highlights and recent developments, please refer to CannaRoyalty's Management's Discussion and Analysis of the Financial Condition and Results of Operations for the Three Months Ended March 31, 2018.

  • On May 11, 2018 Trichome and CannaRoyalty jointly closed a first tranche of $500,000 under a credit agreement to provide up to $2.5 million to 180 Smoke, a leading Canadian online and retail vaporizer products company.
  • On April 18, 2018, CannaRoyalty announced it was planning to acquire 100% of FloraCal Farms, a licensed ultra-premium craft cannabis producer. The acquisition of FloraCal will add branded premium cannabis flower and pre-roll products to CannaRoyalty's diverse portfolio.
  • On March 27, 2018, CannaRoyalty announced it had closed the acquisition of Alta Supply Inc. a California based licensed cannabis distributor and of Kaya Management Inc., the exclusive manufacturer and license holder of rights for Bhang® brand vaporizer products in California, as well as the acquisition of the exclusive statewide manufacturing and distribution rights to Bhang® edibles and Bhang® concentrates in California.
  • On March 25, 2018, the Company announced that it entered into a binding term sheet for the acquisition of 100% of River Distribution and its affiliates to further expand its owned-distribution network across the state of California.

Financial Highlights – Q1 – 2018

Operating Results
All comparisons below are to March 31, 2017, unless otherwise noted

  • Revenues were $643,437 as compared to $301,111.
  • Gross margin was ($29,630) as compared to $244,473.
  • Operating expenses were $4.5 million as compared to $3.1 million.
  • Net loss of $4.7 million as compared to $2.1 million.
  • Net loss per share of $0.10 as compared to $0.05.
  • Adjusted EBITDA loss of $2.1 million as compared to $1.6 million.
  • Adjusted EBITDA loss per share of $0.05 as compared to $0.04.

Balance Sheet
All comparisons below are to December 31, 2017, unless otherwise noted

  • Cash and cash equivalents of $6,056,470 as compared to $4,522,644.
  • Total assets of $67,670,691 as compared to $46,139,757.
  • Current assets of $11,530,330 as compared to $7,947,975.
  • Current liabilities of $7,928,271 as compared to $2,134,270.
  • Long-term debt of $2,569,094 as compared to $2,258,467.
  • Shareholders' equity of $53,740,121 as compared to $40,468,344.

Results of Operations (Summary)
The following tables set forth consolidated statements of financial information for the three-month periods ending March 31, 2018 and March 31, 2017. For further information regarding the Company's financial results for these periods, please refer to the Company's Management's Discussion and Analysis for the periods ended March 31, 2018 and March 31, 2017 and the Company's Financial Statements for the periods ended March 31, 2018, published on CannaRoyalty's issuer profile on SEDAR at www.sedar.com and the Company's website at www.cannaroyalty.com.

Revenue Components

Three months ended March 31

2018

2017

Product sales

$

84,773

$

-

Services

429,817

71,045

Royalties

119,058

211,322

Interest income

9,789

18,744

Total

$

643,437

$

301,111

Cost of sales by revenue type

Three months ended March 31

2018

2017

Cost of product sales

$

75,673

$

-

Cost of services

209,023

11,810

Cost of royalties

388,371

44,828

Total

$

673,067

$

56,638

Gross margin amounts and percentages by revenue type

Three months ended March 31

2018

2017

Products

$

9,099

$

-

Services

220,794

59,235

Royalties

(269,312)

166,494

Interest

9,789

18,744

Total

$

(29,630)

$

244,473

Three months ended March 31

2018

2017

Products

11%

n/a

Services

51%

83%

Royalties

(226%)

79%

Interest

100%

100%

All Types

(5%)

81%

Operating Expenses

Three months ended March 31

2018

2017

Sales and marketing

$

478,516

$

236,860

Research and development

75,965

476,241

General and administrative

3,750,426

2,137,188

Amortization of intangibles

175,107

202,472

Total

$

4,480,014

$

3,052,761

Adjusted EBITDA2

Three months ended March 31

2018

2017

Add (Subtract)

Net loss for the period

$

(4,654,473)

$

(2,053,785)

Amortization of property and equipment

45,268

41,742

Amortization of intangible assets

175,107

202,472

Amortization of royalty investments

388,370

28,263

Interest expense

319,990

17,620

Interest income

(9,789)

(18,744)

Current income taxes

434

-

Deferred income tax recovery

168,813

(78,372)

EBITDA

(3,566,280)

(1,860,804)

Gains on investments

(342,106)

-

Impairment of convertible notes receivable

375,472

-

Listing expense

-

38,193

Gain on reclassification to assets held for sale

-

(98,674)

Adjustment from non-completion of share swap transaction

-

183,475

Share based compensation

1,940,043

1,158,396

Gain on dilution of equity accounted investment

(846,925)

(1,132,107)

Transaction costs on acquisitions

282,126

-

Foreign exchange

76,030

125,652

TOTAL ADJUSTED EBITDA

$

(2,081,640)

$

(1,585,869)

Weighted average number of common shares outstanding - basic and diluted

45,075,695

38,865,970

ADJUSTED EBITDA per share - basic and diluted

$

(0.05)

$

(0.04)

2Adjusted EBITDA and Adjusted EBITDA per share are non-IFRS measures. See "Adjusted EBITDA" in the Company's Management's Discussion and Analysis for the three and twelve-month periods ended March 31, 2018.

Share Capital

The Company's authorized share capital is an unlimited number of common shares of which 46,907,628 were issued and outstanding as at March 31, 2018 (December 31, 2017 – 43,898,445 common shares). The Company has issued 4,109,650 RSUs that have not been exercised as at March 31, 2018 including 2,375,922 that have vested (December 31, 2017 – 4,153,150 including 1,933,587 that had vested).  As of March 31, 2018, there are share purchase warrants and broker warrants outstanding that can potentially be converted to 2,623,491 shares (December 31, 2017 – 4,112,712).

Conference Call

CannaRoyalty will host a conference call on, Tuesday, May 29, 2018 at 8:30 a.m. (Eastern Time) to discuss its 2018 first quarter financial results. The call will be chaired by Marc Lustig, Chief Executive Officer, Afzal Hasan, President and General Counsel and François Perrault, Chief Financial Officer.

Participant Dial-in

Webcast

Reference Number

Conference Call

647-427-7450; or

1-888-231-8191

https://bit.ly/2G0yhbz

Replay

(available for 2 weeks)

416-849-0833; 613-667-0035; or

1-855-859-2056

5898535

About CannaRoyalty

CannaRoyalty is an active operator and investor in the global cannabis industry, with a strong focus on California, the world's largest cannabis market. Our core mission is to become the leading global consumer product goods company for discerning cannabis consumers. We are currently focused on building a diversified portfolio of manufacturing, distribution, intellectual property, and infrastructure assets to achieve this goal. Our leadership team combines a passion and hands-on understanding of the cannabis industry, with seasoned financial and legal expertise. CannaRoyalty's shares trade on the Canadian Stock Exchange (CSE) under the symbol CRZ and internationally on the OTCQX under the symbol CNNRF.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in CannaRoyalty's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward- looking statements.

Forward-looking statements may include, without limitation, statements including the Company's expectations with respect to pursuing new opportunities, anticipated timing for release of the Company's financial results and filing of its final prospectus, and its future growth and other statements of fact.

Although CannaRoyalty has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements,  there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal Laws; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. CannaRoyalty disclaims any intention or obligation to update or revise such information, except as required by applicable law, and CannaRoyalty does not assume any liability for disclosure relating to any other company mentioned herein.

Consolidated Statements of Loss and Comprehensive Loss
In Canadian dollars

Three months ended March 31,

2018

2017

Revenue

$

643,437

$

301,111

Cost of sales

(673,067)

(56,638)

Gross margin

(29,630)

244,473

Operating expenses

Sales and marketing

478,516

236,860

Research and development

75,965

476,241

General and administrative

3,750,426

2,137,188

Amortization of brands and technologies

175,107

202,472

Loss from operations

(4,509,644)

(2,808,288)

Other income (expenses)

Changes in fair value of investments

342,106

-

Impairment of convertible notes receivable

(375,472)

-

Profit from equity accounted investees, net of tax

453,804

942,397

Foreign exchange loss

(76,030)

(125,652)

Interest expense

(319,990)

(17,620)

Adjustment from non-completion of share swap transaction

-

(183,475)

Listing expense

-

(38,193)

Gain on reclassification to assets held for sale

-

98,674

Interest income

-

-

Net loss before tax

(4,485,226)

(2,132,157)

Current tax expense

(434)

-

Deferred tax expense recovery

(168,813)

78,372

Net loss for the period

$

(4,654,473)

$

(2,053,785)

Other comprehensive loss for the period

Foreign currency translation differences

545,605

(87,180)

Total comprehensive loss for the period

$

(4,108,868)

$

(2,140,965)

Net loss per common share - basic and diluted

$

(0.10)

$

(0.05)

Weighted average number of common shares outstanding - basic and diluted

45,075,695

38,865,970

Total net loss for the period attributable to:

Owners of the company

$

(4,629,003)

$

(2,037,970)

Attributable to non-controlling interest

(25,470)

(15,815)

$

(4,654,473)

$

(2,053,785)

Total comprehensive loss for the period attributable to:

Owners of the company

$

(4,083,398)

$

(2,125,150)

Attributable to non-controlling interest

(25,470)

(15,815)

$

(4,108,868)

$

(2,140,965)

Consolidated Statements of Financial Position
In Canadian dollars

March 31, 2018

December 31, 2017

ASSETS

Current

Cash

$

6,056,470

$

4,522,644

Amounts receivable

1,099,646

1,429,123

Inventory

3,015,273

270,169

Prepaid and other assets

727,472

250,744

Loans receivable - current

631,469

1,102,168

Convertible notes - current

-

373,127

11,530,330

7,947,975

Non-Current

Loans receivable

-

66,421

Interest in equity accounted investees

4,087,128

3,596,333

Investments

17,665,449

17,243,342

Royalty investments

7,311,573

5,834,613

Property and equipment

1,329,338

1,084,098

Intangible assets

12,528,608

5,607,598

Goodwill

13,218,265

4,759,377

56,140,361

38,191,782

Total Assets

$

67,670,691

$

46,139,757

LIABILITIES

Current

Amounts payable and accrued liabilities

$

6,898,672

$

1,606,689

Loan payable

533,274

425,345

Current tax liability

496,325

102,236

7,928,271

2,134,270

Non-Current

Convertible debt

1,461,614

1,431,950

Line of credit

1,107,480

826,517

Deferred tax liability

3,433,205

1,278,676

6,002,299

3,537,143

Total Liabilities

$

13,930,570

$

5,671,413

SHAREHOLDERS' EQUITY

Share capital

$

61,233,717

$

50,007,891

Share subscription and contingent shares

5,839,730

-

Warrants reserve

2,575,947

4,149,703

Contributed surplus

11,720,275

9,902,292

Accumulated other comprehensive loss

(487,114)

(1,032,719)

Accumulated deficit

(27,119,958)

(22,381,817)

Non-controlling interest

(22,476)

(177,006)

Shareholders' Equity

53,740,121

40,468,344

Total Liabilities & Shareholders' Equity

$

67,670,691

$

46,139,757

Consolidated Statements of Cash Flows
In Canadian dollars

Three months ended March 31

2018

2017

CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES

Net loss for the period

$

(4,654,473)

$

(2,053,785)

Items not affecting cash:

Bad debts expense

(20,903)

(13,318)

Non controlling interest

-

(15,815)

Gain from equity accounted investees

(453,804)

(942,397)

Amortization of property and equipment

45,268

41,742

Amortization of intangibles

166,868

202,472

Amortization of royalties

388,370

21,121

Amortization of fees related to line of credit

197,630

-

Share based compensation

1,940,043

1,158,396

Deferred tax expense (recovery)

168,813

(78,372)

Loss on impairment of convertible notes receivable

375,472

-

Accretion of derivative assets and liabilities

14,664

-

Gain on reclassification of assets held for sale

-

(98,674)

Gain on investments

(342,106)

-

(2,174,158)

(1,778,630)

Changes in non-cash items relating to operations:

Decrease (increase) in amounts receivable

75,133

(249,641)

Decrease in inventory

13,401

41,085

Increase in prepaid and other assets

(288,276)

(58,918)

(Increase) Decrease in accounts payable and accruals

440,819

(408,506)

Increase in current tax liability

434

-

(1,932,647)

(2,454,610)

CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES

Purchase of property and equipment

(20,530)

(70,304)

Purchase of Kaya and Alta, net of cash received

733,321

-

Purchase of interests in equity accounted investments

-

(1,601,218)

Royalty financing arrangements

(1,290,000)

-

Loans advanced to debtors, net of repayment

(916,360)

(664,535)

(1,493,569)

(2,336,057)

CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES

Proceeds from shares in bought deal financing, net of issuance costs

-

10,963,049

Proceeds from issuance of warrants, net of issuance costs

-

2,787,000

Proceeds from exercise of warrants

4,738,146

29,250

Proceeds from shares issued to minority holders of Trichome

180,000

Proceeds from issuance of stock options

-

25,000

Tax withholding paid on exercise of restricted share units

-

(13,110)

4,918,146

13,791,189

Effect of movement of exchange rates on cash held

41,896

-

INCREASE (DECREASE) IN CASH

1,533,826

9,000,522

CASH, BEGINNING OF PERIOD

4,522,644

2,945,895

CASH, END OF PERIOD

$

6,056,470

$

11,946,417

SOURCE CannaRoyalty Corp.

View original content: http://www.newswire.ca/en/releases/archive/May2018/29/c4972.html

Marc Lustig, CEO, info@cannaroyalty.com, 1-844-556-5070, www.cannaroyalty.com; Jonathan Ross, LodeRock Advisors Inc., jon.ross@loderockadvisors.com, 416-283-0178Copyright CNW Group 2018

View original source (CNW)CannaRoyalty Corp on 6ix

Story so far

Earlier from CannaRoyalty

Later from CannaRoyalty

All CannaRoyalty news releases